02016D2009 — EN — 03.12.2019 — 002.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING DECISION (EU) 2016/2009

of 15 November 2016

approving the vaccination programmes against lumpy skin disease submitted by the Member States

(notified under document C(2016) 7219)

(Only the Bulgarian, Croatian and Greek texts are authentic)

(Text with EEA relevance)

(OJ L 310 17.11.2016, p. 66)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION IMPLEMENTING DECISION (EU) 2019/82 Text with EEA relevance of 17 January 2019

  L 18

48

21.1.2019

►M2

COMMISSION IMPLEMENTING DECISION (EU) 2019/2011 Text with EEA relevance of 28 November 2019

  L 312

93

3.12.2019




▼B

COMMISSION IMPLEMENTING DECISION (EU) 2016/2009

of 15 November 2016

approving the vaccination programmes against lumpy skin disease submitted by the Member States

(notified under document C(2016) 7219)

(Only the Bulgarian, Croatian and Greek texts are authentic)

(Text with EEA relevance)



Article 1

Approval of vaccination programmes against lumpy skin disease

The vaccination programmes against lumpy skin disease listed in the Annex are hereby approved.

Article 2

Applicability

This Decision shall apply until ►M2  20 April 2021 ◄ .

Article 3

Addressees

This Decision is addressed to the Republic of Bulgaria, the Hellenic Republic and the Republic of Croatia.

▼M1




ANNEX

— 
The vaccination programme submitted by Greece.
— 
The vaccination programme submitted by Bulgaria.